Polaryx Therapeutics, Inc. (PLYX)
↓ Download CSVKey ratios (FY2025)
-196.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Income | -$7.82M | -$4.35M | — |
| Net Income | -$8.98M | -$30.36M | — |
| EPS (Diluted) | $-0.20 | $-0.89 | — |
| Total Assets | $5.17M | $5.00M | — |
| Total Liabilities | $605.0K | $289.0K | — |
| Shareholders' Equity | $4.57M | $4.71M | $1.28M |
| Cash & Equivalents | $5.14M | $4.62M | — |
| Operating Cash Flow | -$3.94M | -$2.57M | — |
| Shares Outstanding | 47.34M | 41.15M | — |